Clinical Trial Update: RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 trial evaluating pemvidutide for alcohol use disorder in people with overweight or obesity. The study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Obesity

Drugs mentioned

• Pemvidutide (Pemvidutide)

Snippet

Sponsor: Altimmune, Inc. | Conditions: Alcohol Use Disorder (AUD) | Phase 2 | Status: ACTIVE_NOT_RECRUITING